Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
Agios Pharmaceuticals | 1,633 | 2022 | |||||||||
SEI Investments | 10,342 | 2024q2 | |||||||||
Corcept Therapeutics | 2,432 | 2021 | |||||||||
Gentex | 7,016 | 2023q3 | |||||||||
Genmab | 14,947 | 2024q1 | |||||||||
Nano-X Imaging | 474 | 2022 | |||||||||
Π£ΡΠ°ΠΎΡΠ³ΡΠΈΠ½ΡΠ΅Π· | 72 | 2024q2 | |||||||||
iTeos Therapeutics | 626 | 2023q3 | |||||||||
Aurinia Pharmaceuticals | 958 | 2021 | |||||||||
Π‘ΡΡΠ³ΡΡΠ½Π΅ΡΡΠ΅Π³Π°Π· | 11,868 | 2023 | |||||||||
Ennis | 574 | 2025q2 | |||||||||
Aspen Technology | 12,855 | 2022 | |||||||||
CD Projekt | 2,626 | 2021 | |||||||||
Vaxcyte | 3,786 | 2021 | |||||||||
Achilles Therapeutics | 40 | 2023q3 | |||||||||
Legacy Housing | 631 | 2022 | |||||||||
Denison Mines | 1,914 | 2024q1 | |||||||||
Proto Labs | 817 | 2023q3 | |||||||||
Π£ΡΠ°Π»ΡΡΠΊΠ°Ρ ΠΊΡΠ·Π½ΠΈΡΠ° | 123 | 2024q2 | |||||||||
ΠΠΎΡΠΎΠ²ΠΈΡΡΠΊΠΈΠΉ ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Ρ ΠΎΠ³Π½Π΅... | 22 | 2023 |